NetworkNewsBreaks – Lexaria Bioscience Corp. (NA
Post# of 421
(Total Views: 238)
Posted On: 10/12/2021 5:02:17 PM
NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Featured in ‘Stock2Me’ Podcast
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in the latest episode of the “Stock2Me Podcast,” an IBN (InvestorBrandNetwork) solution to provide specialized content distribution via widespread syndication channels. Lexaria’s CEO and Chairman Chris Bunka joined the latest episode to discuss the company’s business model, his professional background and the team behind Lexaria, as well as the company’s recent transformative steps to position it for accelerated growth. “Our company kind of had a rebirth in January 2021. … We completed a 1-for-30 reverse stock split,” Bunka explained. “That was really hard, and just so you all know, I was the biggest shareholder. I am still the biggest shareholder. I took a big hit on my own holdings, but we had to do that to make the company attractive for future shareholders. … We got listed on Nasdaq in January and completed an $11 million financing. That was the biggest financing in the history of the company, and it transformed us. … We were able to step on the gas pedal and basically work on our research and development and our commercial studies at a 5-10x higher pace than anything we could do in the past. Therefore, this year, we’ve done more work than we did in the five years previous — all put together.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in the latest episode of the “Stock2Me Podcast,” an IBN (InvestorBrandNetwork) solution to provide specialized content distribution via widespread syndication channels. Lexaria’s CEO and Chairman Chris Bunka joined the latest episode to discuss the company’s business model, his professional background and the team behind Lexaria, as well as the company’s recent transformative steps to position it for accelerated growth. “Our company kind of had a rebirth in January 2021. … We completed a 1-for-30 reverse stock split,” Bunka explained. “That was really hard, and just so you all know, I was the biggest shareholder. I am still the biggest shareholder. I took a big hit on my own holdings, but we had to do that to make the company attractive for future shareholders. … We got listed on Nasdaq in January and completed an $11 million financing. That was the biggest financing in the history of the company, and it transformed us. … We were able to step on the gas pedal and basically work on our research and development and our commercial studies at a 5-10x higher pace than anything we could do in the past. Therefore, this year, we’ve done more work than we did in the five years previous — all put together.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)